Advances in RIPK1 kinase inhibitors (vol 13, 976435, 2022)

被引：0
|
作者：
Frontiers Prod Off [1 ]
机构：
[1] Frontiers Media SA, Lausanne, Switzerland
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 13卷
关键词：
inhibitor; receptor interacting protein 1 (RIP1); programmed necrosis; necrosis; RIP1 (RIPK1);
D O I：
10.3389/fphar.2022.1123234
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
    Mifflin, Lauren
    Ofengeim, Dimitry
    Yuan, Junying
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (08) : 553 - 571
  • [32] RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events
    Delanghe, Tom
    Dondelinger, Yves
    Bertrand, Mathieu J. M.
    TRENDS IN CELL BIOLOGY, 2020, 30 (03) : 189 - 200
  • [33] Synthesis and evaluation of hybrid molecules as RIPK1 and HDACs dual inhibitors
    Tang, Mingze
    Zhou, Xuan
    Shen, Qianqian
    Fang, Chen
    Peng, Xia
    Ji, Yinchun
    Zhu, Guijun
    Geng, Meiyu
    Chen, Yi
    Duan, Wenhu
    Ai, Jing
    Zhang, Hefeng
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1318
  • [34] RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
    Ke, Dan
    Zhang, Zhen
    Liu, Jieting
    Chen, Peijian
    Dai, Yucen
    Sun, Xinhai
    Chu, Yanhui
    Li, Luxin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond (vol 14, 1114103, 2023)
    Liu, Xiaoyu
    Tang, A-Ling
    Chen, Jie
    Gao, Nan
    Zhang, Guoqiang
    Xiao, Cheng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
    Liu, Xiaoyu
    Tang, A-Ling
    Chen, Jie
    Gao, Nan
    Zhang, Guoqiang
    Xiao, Chen
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [37] Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide
    Saleh, Danish
    Najjar, Malek
    Zelic, Matija
    Shah, Saumil
    Nogusa, Shoko
    Polykratis, Apostolos
    Paczosa, Michelle K.
    Gough, Peter J.
    Bertin, John
    Whalen, Michael
    Fitzgerald, Katherine A.
    Slavov, Nikolai
    Pasparakis, Manolis
    Balachandran, Siddharth
    Kelliher, Michelle
    Mecsas, Joan
    Degterev, Alexei
    JOURNAL OF IMMUNOLOGY, 2017, 198 (11): : 4435 - 4447
  • [38] Pancreatic beta cells are resistant to RIPK1 kinase-mediated death
    Takiishi, T.
    Xiao, P.
    Gurzov, E. A.
    Bertrand, M.
    Cardozo, A. K.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S202 - S202
  • [39] Discovery of potential RIPK1 inhibitors by machine learning and molecular dynamics simulations
    Liu, Ji-xiang
    Na, Ri-song
    Yang, Lian-juan
    Huang, Xu-ri
    Zhao, Xi
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2023, 25 (45) : 31418 - 31430
  • [40] Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
    Xin, Yufeng
    Dai, Pengcheng
    Shao, Hongming
    Zhuang, Chunlin
    Li, Jiao
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
12345